Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma.
Maesaka K, Sakamori R, Yamada R, Tahata Y, Ohkawa K, Oshita M, Tamura S, Hagiwara H, Mita E, Yakushijin T, Inada M, Kodama T, Hikita H, Tatsumi T, Takehara T.
Maesaka K, et al. Among authors: takehara t.
Anticancer Res. 2021 Apr;41(4):2187-2192. doi: 10.21873/anticanres.14993.
Anticancer Res. 2021.
PMID: 33813432
Clinical Trial.